수혈 기기 시장 - 세계 산업 규모, 점유율, 동향, 기회, 예측 : 제품별, 최종 용도별, 지역별, 경쟁(2020-2030년)

The Global Blood Transfusion Devices Market was valued at USD 4.80 Billion in 2024 and is projected to reach USD 6.61 Billion by 2030, growing at a CAGR of 5.68%. Blood transfusion devices, which include blood bags, transfusion filters, infusion pumps, and apheresis systems, are vital for ensuring the safe and efficient collection, processing, and administration of blood components. The increasing prevalence of medical conditions such as anemia, cancer, hemophilia, and kidney disease-which often necessitate recurrent transfusions-is a key factor propelling market growth.

Additionally, the rise in emergency cases, including trauma and obstetric complications, particularly in developing nations with expanding healthcare systems, continues to drive demand. While financial and logistical challenges remain, the market outlook is positive due to technological advancements, increased healthcare spending, and heightened focus on safety and efficiency in transfusion practices. As both developed and emerging markets enhance their healthcare infrastructure, the integration of advanced transfusion technologies is set to accelerate.

Key Market Drivers

Growth in Healthcare Industry

The expanding global healthcare industry is a key driver supporting the growth of the blood transfusion devices market. Generating over USD 4 trillion annually, the healthcare sector includes pharmaceuticals, biotechnology, medical technology, and diagnostics-each playing a pivotal role in supporting transfusion needs.

Rising rates of surgical procedures, organ transplants, cancer treatments, and emergency interventions require reliable access to blood components like red cells, platelets, and plasma. However, disparities remain-only 6% of the 313 million global procedures occur in the poorest regions, despite these areas housing over a third of the global population. This imbalance results in higher fatality rates for treatable conditions. With more hospitals and clinics being established, especially in underserved regions, demand for transfusion equipment continues to rise, driven by both clinical need and improvements in infrastructure.

Key Market Challenges

High Capital and Operational Costs

The significant costs associated with blood transfusion equipment remain a major challenge for market expansion. Advanced technologies have improved the quality and safety of transfusion procedures but have also raised the financial barriers for adoption.

Establishing modern transfusion facilities requires substantial investment in equipment such as apheresis machines, automated processing systems, and temperature-controlled storage units. In low- and middle-income countries, these upfront and ongoing operational costs often hinder adoption, limiting the reach of quality transfusion care. Budget constraints among healthcare providers further exacerbate disparities in access, affecting both availability and patient outcomes.

Key Market Trends

Expansion of Decentralized Blood Collection Models

An important trend shaping the blood transfusion devices market is the transition toward decentralized collection models. To improve the resilience and reach of blood supply systems, healthcare systems are increasingly deploying mobile collection units, community-based sites, and rural health posts in addition to central facilities.

Innovations such as Touch Activated Phlebotomy (TAP) devices are enhancing the convenience and safety of decentralized blood collection by enabling painless, reliable, and self-administered capillary blood draws-without the need for trained phlebotomists. These models offer scalable, flexible solutions for broader population coverage, especially in hard-to-reach areas.

Key Market Players

• Immucor Inc.
• Becton Dickinson and Company
• B. Braun Melsungen AG
• Terumo Corporation
• Grifols SA
• Kaneka Corporation
• Fresenius Kabi AG
• Haemonetics Corporation
• Macopharma SA
• Ecomed Solutions, LLC.

Report Scope

In this report, the Global Blood Transfusion Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Blood Transfusion Devices Market, By Product:

• Apheresis Systems
• Infusion Devices
• Blood Warmers
• Venous Access Devices
• Filters
• Others

Blood Transfusion Devices Market, By End Use:

• Hospital
• Ambulatory Surgical Centers
• Dialysis Centers
• Blood Bank
• Others

Blood Transfusion Devices Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Blood Transfusion Devices Market.

Available Customizations

Global Blood Transfusion Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Impact of COVID-19 on Global Blood Transfusion Devices Market

5. Global Blood Transfusion Devices Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Apheresis Systems, Infusion Devices, Blood Warmers, Venous Access Devices, Filters, Others)
  • 5.2.2. By End Use (Hospital, Ambulatory Surgical Centers, Dialysis Centers, Blood Bank, Others)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Market Map

6. North America Blood Transfusion Devices Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By End Use
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Blood Transfusion Devices Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By End Use
  • 6.3.2. Mexico Blood Transfusion Devices Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By End Use
  • 6.3.3. Canada Blood Transfusion Devices Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By End Use

7. Europe Blood Transfusion Devices Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By End Use
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Blood Transfusion Devices Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By End Use
  • 7.3.2. Germany Blood Transfusion Devices Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By End Use
  • 7.3.3. United Kingdom Blood Transfusion Devices Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By End Use
  • 7.3.4. Italy Blood Transfusion Devices Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By End Use
  • 7.3.5. Spain Blood Transfusion Devices Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By End Use

8. Asia Pacific Blood Transfusion Devices Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By End Use
  • 8.2.3. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Blood Transfusion Devices Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By End Use
  • 8.3.2. India Blood Transfusion Devices Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By End Use
  • 8.3.3. South Korea Blood Transfusion Devices Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By End Use
  • 8.3.4. Japan Blood Transfusion Devices Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By End Use
  • 8.3.5. Australia Blood Transfusion Devices Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By End Use

9. South America Blood Transfusion Devices Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By End Use
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Blood Transfusion Devices Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By End Use
  • 9.3.2. Argentina Blood Transfusion Devices Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By End Use
  • 9.3.3. Colombia Blood Transfusion Devices Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By End Use

10. Middle East and Africa Blood Transfusion Devices Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By End Use
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Blood Transfusion Devices Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By End Use
  • 10.3.2. Saudi Arabia Blood Transfusion Devices Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By End Use
  • 10.3.3. UAE Blood Transfusion Devices Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By End Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Disruptions : Conflicts, Pandemics and Trade Barriers

14. Global Blood Transfusion Devices Market: SWOT Analysis

15. Porters Five Forces Analysis

• 15.1. Competition in the Industry
• 15.2. Potential of New Entrants
• 15.3. Power of Suppliers
• 15.4. Power of Customers
• 15.5. Threat of Substitute Products

16. Competitive Landscape

• 16.1. Immucor Inc.
  • 16.1.1. Business Overview
  • 16.1.2. Company Snapshot
  • 16.1.3. Products & Services
  • 16.1.4. Financials (As Reported)
  • 16.1.5. Recent Developments
  • 16.1.6. Key Personnel Details
  • 16.1.7. SWOT Analysis
• 16.2. Becton Dickinson and Company
• 16.3. B. Braun Melsungen AG
• 16.4. Terumo Corporation
• 16.5. Grifols SA
• 16.6. Kaneka Corporation
• 16.7. Fresenius Kabi AG
• 16.8. Haemonetics Corporation
• 16.9. Macopharma SA
• 16.10. Ecomed Solutions, LLC.

17. Strategic Recommendations

18. About Us & Disclaimer